Northwest Biotherapeutics Inc (NASDAQ:NWBO)

CAPS Rating: 1 out of 5

Results 1 - 16 of 16

Recs

0
Member Avatar Allstar13913 (99.83) Submitted: 9/11/2014 10:55:29 PM : Underperform Start Price: $5.80 NWBO Score: +11.65

Stock promotion pump and dump scheme that uses Redchip.com, a known promoter. Is now altering phase 3 studies because the cancer drug efficacy is not as advertised.

Recs

0
Member Avatar naughtyguy (33.44) Submitted: 8/8/2014 2:04:15 PM : Outperform Start Price: $6.47 NWBO Score: -23.87

Very promising cancer vaccine! Lots of law firms claim to be investigating them, but none have filed any claims. They have helped the stock price remain attractive, however.

Recs

0
Member Avatar ChiSox79 (< 20) Submitted: 3/30/2014 2:02:44 PM : Outperform Start Price: $7.02 NWBO Score: -33.01

Asco abstract will result in increased share price, particularly in the lead-up to the event

Recs

0
Member Avatar shawanator1 (< 20) Submitted: 3/12/2014 3:50:01 PM : Outperform Start Price: $8.05 NWBO Score: -41.56

helping cancer patients to live longer

Recs

1
Member Avatar martynanasi (98.48) Submitted: 3/11/2014 12:10:09 PM : Outperform Start Price: $9.94 NWBO Score: -52.74

Recently approved drug DCVax-L apporved in Germany ahead of phase III trail completion. WIll be allowed to prescribed for 5yr and can be extended. Previous trials point to sustain life span of existing brain cancer tumor patients. See huge upside

Recs

0
Member Avatar karlsmq (< 20) Submitted: 3/10/2014 5:42:19 PM : Outperform Start Price: $8.29 NWBO Score: -42.60

EXCELLENT PIPELINE OF ANTI CANCER ..

Recs

0
Member Avatar Alex68 (< 20) Submitted: 3/7/2014 6:45:27 PM : Outperform Start Price: $4.49 NWBO Score: +4.21

meet nwbo ONCS

Recs

0
Member Avatar leeivyca (77.05) Submitted: 1/5/2014 7:30:34 PM : Outperform Start Price: $4.12 NWBO Score: +13.75

It has break-thru technology

Recs

4
Member Avatar zzlangerhans (99.82) Submitted: 12/27/2013 9:48:59 AM : Underperform Start Price: $3.69 NWBO Score: -26.82

Long-term Northwest shareholders make me think of a particularly dumb herd of wildebeest on the Serengeti. A couple of weeks ago a pride of lions pounced on the Immunocellular wildebeests and tore them to bits. The Northwest wildebeests snorted and paced around for a bit. A few of the smarter ones broke and ran for the forest cover. The rest quickly forgot about what happened to Immunocellular and started grazing again. The lions salivated.

The only reason I'd buy a share of Northwest for more than a nickel is because I could sell it right away for a profit. If you told me I was locked up for two years, forget it. Those wildebeest are doomed. I've seen that nature show too many times.

Recs

0
Member Avatar TMFBiologyFool (96.90) Submitted: 12/17/2013 12:07:34 PM : Underperform Start Price: $3.44 NWBO Score: -34.12

Dendridic immunotherapy is weak.

Recs

0
Member Avatar MyCruiseWright2 (54.62) Submitted: 11/12/2013 7:10:45 PM : Outperform Start Price: $4.75 NWBO Score: -6.18

Work in biotech for 36 yrs and know until phase 3 shows efficacy chances of success are low. However, positive results in phase 2 trials especially with brain cancer is worth the role of the dice. Don't bet the bank, 100 or 200 shares is not too expensive for a potentially significant gain.

Recs

0
Member Avatar bakpakr34 (< 20) Submitted: 11/9/2013 10:16:33 PM : Outperform Start Price: $3.87 NWBO Score: +17.62

Brain, prostate, ovarian cancer vaccines are in late trials.

Recs

0
Member Avatar jamespeer (24.45) Submitted: 11/7/2013 8:39:57 AM : Underperform Start Price: $3.15 NWBO Score: -46.44

losing money every quarter, that $1.98M in cash is not going to last much longer...

Recs

0
Member Avatar BuffettJunior1 (97.50) Submitted: 10/1/2012 8:48:21 PM : Underperform Start Price: $8.00 NWBO Score: +70.84

Reverse split wont keep this stock from crashing.

Recs

0
Member Avatar Mgmirage (< 20) Submitted: 7/31/2011 3:34:51 PM : Outperform Start Price: $9.12 NWBO Score: -92.38

Technology two decades in the making reaching maturity in the next 24months

Recs

0
Member Avatar SwingStockSurfer (< 20) Submitted: 2/15/2011 9:57:39 PM : Outperform Start Price: $12.00 NWBO Score: -102.26

The advantages over DNDN are dramatic. It's just a matter of time.

Results 1 - 16 of 16

Featured Broker Partners


Advertisement